Quality of life in older patients with congestive heart failure: Effects of ACE inhibitors

Drugs and Aging

Volumn 8, Issue 1, 1996, Pages 23-28

  Fergus, Icilma ^a   Demopoulos, Laura A ^a   LeJemtel, Thierry H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

AGE; AGED; ANEMIA; ARTHRITIS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; EXERCISE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; LIFE EXPECTANCY; LUNG DISEASE; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW;

EID: 0030045707     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199608010-00005     Document Type: Review

References (45)

1. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121: 951-7
2. Ho KKL, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-15
3. Cody RJ. Characteristics of the elderly patient with congestive heart failure. Am J Geriatr Cardiol 1992; 1: 30-41
4. Swedberg K, Held P, Kjekshus J, et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327: 678-84
5. SOLVD Investigators. Effect of angiotensin converting enzyme inhibitor enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302
6. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91
7. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669-77
8. Armstrong PW, Moe GW. Medical advances in the treatment of congestive heart failure. Circulation 1994; 88: 2941-52
9. Rector TS, Francis GS, Cohn JN. Patient's self-assessment of their congestive heart failure. Part I: patient perceived dysfunction and its poor correlation with maximal exercise tests. Heart Failure 1987; 3: 192-6
10. Rector TS, Kubo SH, Cohn JN. Patient's self-assessment of their congestive heart failure. Part II: content, reliability and validity of the new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987; 3: 198-209
11. Mayou R. Quality of life in CHF: is it more important than prolonged survival? A psychiatrist's perspective. Controversies Cardiol 1994; 5 (3): 9-12
12. Guyatt GH. Measurement of health-related quality of life in heart failure J Am Coll Cardiol 1993; 22: 185A-91A
13. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994; 272: 619-26
14. Guyatt GH, Cook DJ. Health status, quality of life, and the individual [commentary]. JAMA 1994; 272: 630-1
15. Rector TS, Johnson G, Dunkman WB, et al. Evaluation of patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. Circulation 1993: 87 Suppl. VI: 71-7
16. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 1993; 71: 1106-7
17. Dickstein K, Barvik S, Aarsland T. Effects of long-term enalapril therapy on cardiopulmonary exercise performance after myocardial infarction. Circulation 1991; 83: 1895-904
18. Rector TS, Tschumperlin LK, Kubo SH, et al. Use of the Living with Heart Failure Questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Cardiac Failure 1995; 1: 201-6
19. Wiklund I, Swedberg K. Some methodological problems in analyzing quality of life data in severe congestive heart failure patients. J Clin Res Pharmacoepidemiol 1991; 5: 265-73
20. Rogers WJ, Johnstone DE, Yusuf S, et al. Quality of life among 5025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. J Am Coll Cardiol 1994; 23: 393-400
21. Bijou R, LeJemtel TH, Sonnenblick EH. From left ventricular dysfunction to heart failure in the elderly patient. Am J Geriatr Cardiol 1993; 2: 14-27
22. Lakatta EG. Changes in cardiovascular function with aging. Fur Heart J 1990; 11 Suppl. C: 22-9
23. Rodeheffer RJ, Gerstenblith G, Becker LC. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 1984; 69: 203-13
24. Higginbotham MB, Morris KG, Williams RS, et al. Physiologic basis for the age-related decline in aerobic work capacity. Am J Cardiol 1986; 57: 1374-9
25. Anversa P, Hiler B, Ricci R, et al. Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol 1986; 8: 1441-8
26. Olivetti G, Melissari M, Capasso JM, et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68: 1560-8
27. Wong WF, Gold S, Fukuyama O, et al. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol 1989; 63: 1526-8
28. Bryg RJ, Williams GA, Labovitz AJ. Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol 1987; 59: 971-4
29. Francis GS, Goldsmith SR, Levine B, et al. The neurohormonal axis in congestive heart failure. Ann Intern Med 1984; 101: 370-7
30. Kluger J, Cody RJ, Laragh JH. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Am J Cardiol 1982; 49: 1667-74
31. Weidmann P, Myttenaere-Bursztein S, Maxwell M, et al. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int 1975; 8: 325-33
32. Zozaya J, Viloria M, Castro A. The effect of aging on the renin-angiotensin-aldosterone system and physiological variables in normal subjects. Res Comm Chem Pathol Pharmacol 1983; 42: 463-70
33. Epstein M. Effects of aging on the kidney. Fed Proc 1979; 38: 168-72
34. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992; 85: 1364-73
35. Jondeau G, Katz SD, Zohman L, et al. Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure. Circulation 1992; 86: 1351-6
36. 2 max. J Appl Physiol 1988; 65: 1147-51
37. Holmgren A, Jonsson B, Levander M, et al. Low physical working capacity in suspected heart cases due to inadequate adjustment of peripheral blood flow (vasoregulatory asthenia). Acta Med Scand 1957; 158: 413-36
38. Wahren J, Saltin B, Jorfeldt L, et al. Influence of age on the local circulatory adaptation to leg exercise. Scand J Clin Lab Invest 1974; 33: 79-86
39. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1-6
40. Shephard RJ, Bouhlel E, Vandewalle H. et al Muscle mass as a factor limiting physical work. J Appl Physiol 1988; 64: 1472-9
41. Frontera WR, Meredith CN, O'Reilly KP, et al. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol 1988; 64: 1038-44
42. Kilbom A, Hartley LH, Saltin B, et al. Physical training in sedentary middle-aged and older men. A medical evaluation. Scand J Clin Lab Invest 1969; 24: 315-22
43. Saltin B, Hartley LH, Kilbom A, et al. Physical training in sedentary middle-aged and older men. Oxygen uptake, heart rate, and blood lactate concentration at submaximal and maximal exercise. Scand J Clin Lab Invest 1969; 24: 323-34
44. Fiatarone MA, Marks EC, Ryan ND, et al. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 1990; 263: 3029-34
45. Gundersen T, Wiklund I, Swedberg K, et al. Effects of 12 weeks of ramipril treatment on the quality of life in patients with moderate congestive heart failure: results of a placebo-controlled trial. Cardiovasc Drugs Ther 1995; 9: 589-94